Theratechnologies logo

Theratechnologies Share Price (NASDAQ: THTX)

$3.25

-0.01

(-0.31%)

Live

Last updated on

Check the interactive Theratechnologies Stock chart to analyse performance

Theratechnologies Inc Key Stats

Check Theratechnologies key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.26
Open
$3.26
Market Capitalization
$149.9M
Today's Volume
$112.8K
Revenue TTM
$84.4M
EBITDA
$8.7M
Earnings Per Share (EPS)
$-0.19
Profit Margin
-10.85%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1116.86%

Stock Returns calculator for Theratechnologies Stock including INR - Dollar returns

The Theratechnologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Theratechnologies investment value today

Current value as on today

₹2,50,547

Returns

₹1,50,547

(+150.55%)

Returns from Theratechnologies Stock

₹1,46,212 (+146.21%)

Dollar Returns*

₹4,335 (+4.33%)

Indian investors sentiment towards Theratechnologies Stock

-75%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Theratechnologies Stock from India on INDmoney has decreased by -75% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Theratechnologies Inc

  • Name

    Holdings %

  • Soleus Capital Management, L.P.

    10.44%

  • Nantahala Capital Management, LLC

    5.27%

  • Morgan Stanley - Brokerage Accounts

    4.84%

  • AIGH Capital Management, LLC

    4.53%

  • Stonepine Capital Management Llc

    0.41%

  • Dimensional Fund Advisors, Inc.

    0.23%

Analyst Recommendation on Theratechnologies Stock

Rating
Trend

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Theratechnologies(by analysts ranked 0 to 5 stars)

Theratechnologies Share Price Target

What analysts predicted

Upside of 24.19%

Target:

$4.04

Current:

$3.25

Theratechnologies share price target is $4.04, a slight Upside of 24.19% compared to current price of $3.25 as per analysts' prediction.

Theratechnologies Stock Insights

  • Price Movement

    In the last 6 months, THTX stock has moved up by 79.6%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 25.00M → 17.72M (in $), with an average decrease of 15.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 117.0K → -4.46M (in $), with an average decrease of 3913.7% per quarter
  • THTX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.4% return, outperforming this stock by 174.5%

Theratechnologies Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$85.9M
↑ 5.02%
Net Income
$-8.3M
↓ 65.33%
Net Profit Margin
-9.67%
↑ 19.63%

Theratechnologies Technicals Summary

Sell

Neutral

Buy

Theratechnologies is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Theratechnologies Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Theratechnologies Inc logo
3.16%
75.74%
147.91%
-59.65%
-68.29%
Regeneron Pharmaceuticals, Inc. logo
5.52%
-17.35%
-50.85%
-1.12%
-3.68%
Beone Medicines Ltd logo
6.51%
21.35%
57.45%
73.21%
25.84%
Vertex Pharmaceuticals Incorporated logo
-14.26%
-17.97%
-18.13%
40.27%
45.64%
Alnylam Pharmaceuticals, Inc. logo
39.9%
82.53%
68.83%
115.41%
241.51%

About Theratechnologies Inc

Theratechnologies Inc., a biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its product pipeline includes tesamorelin F8 in HIV-associated lipodystrophy that is in Phase 2 clinical trials for the treatment of nonalcoholic steatohepatitis; SORT1+ Technology that is in Phase 1 clinical trials for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; sudocetaxel zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company also commercializes olezarsen, an RNA-targeted medicine for the treatment of familial chylomicronemia syndrome and severe hypertriglyceridemia; and donidalorsen, an RNA-targeted medicine that targets the acute attacks of hereditary angioedema. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Organization
Theratechnologies
Employees
0
CEO
Mr. Paul Lévesque
Industry
Health Technology

Key Management of Theratechnologies Inc

NameTitle
Mr. Paul Lévesque
President, CEO & Director
Mr. Philippe Dubuc M.B.A., MBA
Senior VP & CFO
Mr. Jocelyn Lafond L.L.M., LL.B.
General Counsel & Corporate Secretary
Dr. Christian Marsolais Ph.D.
Senior VP & Chief Medical Officer
Mr. John Leasure
Global Commercial Officer
Ms. Joanne Choi
Senior Director of Investor Relations
Hon. Andre Dupras M.Sc.
Vice President of Human Resources
Mr. Julie Schneiderman
Senior Director, Communications & Corporate Affairs

Important FAQs about investing in THTX Stock from India :

What is Theratechnologies share price today?

Theratechnologies share price today is $3.25 as on . Theratechnologies share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Theratechnologies share?

Theratechnologies share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Theratechnologies stock price today i.e. is trending at $3.25, lower by 0.31% versus the 52 week high.

How to invest in Theratechnologies Stock (THTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Theratechnologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Theratechnologies Shares that will get you 0.4615 shares as per Theratechnologies share price of $3.25 per share as on August 26, 2025 at 12:40 AM IST.

What is the minimum amount required to buy Theratechnologies Stock (THTX) from India?

Indian investors can start investing in Theratechnologies (THTX) shares with as little as ₹87.537 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.37 in Theratechnologies stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Theratechnologies share’s latest price of $3.25 as on August 26, 2025 at 12:40 AM IST, you will get 3.0769 shares of Theratechnologies. Learn more about fractional shares .

What are the returns that Theratechnologies has given to Indian investors in the last 5 years?

Theratechnologies stock has given -68.29% share price returns and 18.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?